|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4375 | |
| A61K 31/4184 | |||
| A61K 39/395 | |||
| A61K 39/00 | |||
| A61P 35/00 | |||
| A61K 45/06 |
| (11) | Patento numeris | 3481393 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17823723.6 |
| Europos patento paraiškos padavimo data | 2017-06-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2017/053521 |
| Data | 2017-06-14 |
| (87) | Numeris | WO 2018/007885 |
| Data | 2018-01-11 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2016/0885 | 2016-07-05 | WO |
| (72) |
SONG, Jing, CN
WANG, Lai, CN
LI, Kang, CN
ZHANG, Tong, CN
LUO, Lusong, CN
WEI, Min, CN
TANG, Zhiyu, CN
ZHANG, Guoliang, CN
ZHOU, Changyou, US
|
| (73) |
Beigene, Ltd.,
94 Solaris Avenue Camana Bay, Grand Cayman KY1-1108,
KY
|
| (54) | COMBINATION OF A PD-1 ANTAGONIST AND A RAF INHIBITOR FOR TREATING CANCER |
| COMBINATION OF A PD-1 ANTAGONIST AND A RAF INHIBITOR FOR TREATING CANCER |